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The monoclonal antibody technique is providing new reagents for the study 
of mononuclear phagocytes. Among other applications, specific antibodies should 
make it possible to distinguish macrophages from other cell types in suspension 
and tissue sections. This potential has not been fully exploited, since the number 
of specific, panmacrophage reagents is limited. In mouse, a single monoclonal 
antibody, F4/80, appears to be truly macrophage restricted (1, 2). In rat, guinea 
pig, and rabbit, macrophage-specific reagents have yet to be described to our 
knowledge. In man, several antimonocyte antibodies have been produced (3- 
10). However, there has been little work using these reagents to distinguish 
macrophages from dendritic cells and to visualize macrophages in tissue sections. 
The distinction between macrophages and dendritic cells is critical, since the 
two cell types differ so markedly in functional capacities. The dendritic cell lacks 
Fc receptors (2, 1 1, 12), does not exhibit active phagocytic or pinocytic activity 
(1 1), but is the principal accessory cell needed to stimulate lymphocyte responses 
(see 13). Recently it has been shown that enriched populations of dendritic cells 
from human blood are markedly more potent than monocytes in stimulating 
mixed leukocyte reactions and polyclonai T cell mitogenesis (14, 15). 
Here we describe monocional antibodies directed to an antigen that is re- 
stricted to mononuclear phagocytes including monocytes in blood and macro- 
phages in lung, skin, spleen, and lymph node. We then use the monoclonals in 
two types of experiments to further characterize human mononuclear phagocytes 
and dendritic cells. First, depletion of monocytes with antibody and complement 
can be used to prepare circulating dendritic cells in high purity and yield. Second, 
the monoclonals stain macrophages in tissue sections, localizing this cell type to 
the dermis of skin, red pulp of spleen, and lymphatic channels of lymph node. 
In contrast, presumptive dendritic cells are localized in entirely different ana- 
tomic regions: skin epidermis, splenic white pulp, and lymph node cortex. 
Therefore these monoclonal antibodies provide a clear distinction between 
macrophages and dendritic cells in blood and tissues. 
* Supported by grant CA 30198 from the National Institutes of Health. 
Established Investigator of the American Heart Association. 
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Materials and Methods 
Cells. Blood was obtained from normal volunteers, and leukocyte-enriched buffy coats 
were purchased from the Greater New York Blood Center. Mononuclear ceils were 
harvested from the interface of Ficoll-Hypaque (density = 1.077; Histopaque 1077-1; 
Sigma Chemical Co., St. Louis, MO) columns and cultured for 1-2 h on 100-mm plastic 
culture dishes. The medium was 5% heat-inactivated fetal calf serum (FCS) 1 (Sterile 
Systems, Logan, UT, and Kansas City Biologicals, Kansas City, MO)-RPMI 1640 (Grand 
Island Biological Co., Grand Island, NY) supplemented with 20 ttg/ml gentamycin, 100 
U/ml penicillin, 1 mM glutamine, and 5 x 10 -5 M 2-mercaptoethanol. Nonadherent cells 
(~70% of the total) were removed with several washes and used to prepare T cells by 
rosetting with neuraminidase-treated sheep erythrocytes or by nylon wool filtration (14). 
Adherent cells were cultured overnight and separated into monocyte-, B cell-, and 
dendritic cell-enriched fractions as described (14). T lymphoblasts were prepared by 
stimulating nonadherent cells with 2 ug/ml phytohemagglutinin (Burroughs Wellcome & 
Co., Greenville, NC) for 4 d in 5% FCS-RPMI 1640 medium. B lymphoblasts were 
prepared by stimulating high density B cell-enriched fractions (14) with 3 #g/ml pokeweed 
mitogen (Difco Laboratories Inc., Detroit, MI) for 4 d in 5% FCS-RPMI-1640 medium. 
Granulocytes were kindly provided by Dr. H. B. Fleit (The Rockefeller University) who 
sedimented the granulocytes through Ficoli-Hypaque, removed most erythrocytes by 
dextran sedimentation, and depleted residual erythrocytes by hypotonic lysis (16). Platelets 
were present in mononuclear cell fractions and could be isolated because they did not 
pellet at 180 g for 10 rain. To study the stability of cell surface antigens in culture, 
monocyte-enriched fractions were maintained for I -3  wk either adherent to glass cover- 
slips in 10% AB+ human serum-RPMI 1640, in plastic culture dishes in 5% FCS-RPMI 
1640, or in teflon beakers as described (17; kindly provided by Dr. S. B. Wright). The 
cultured cells were >98% viable monocytes by morphology, nonspecific esterase reactivity, 
and binding of specific monoclonal antibodies. Dr. A. Fels and Dr. T. Nash (The 
Rockefeller University) provided alveolar macrophages by bronchial lavage of nonsmok- 
ers, followed by collection of mononuclear cells on Ficoll-Hypaque columns, and adher- 
ence to glass coverslips (18). Several human cell lines were provided by Dr. J. C. Unkeless 
(The Rockefeller University) and Dr. H. B. Fleit: HL60 (promyelocyte-like), K562 
(multipotential blood cell precursor), U937 (immature myeloid), and Daudi (B cell). 
Several human lymphocyte lines were provided by Dr. L. Mayer (The Rockefeller 
University): T cell lines CEM T and Jurkat, and B cell lines SeHa D, 8866P, and 32al. 
Monodona l  Antibodies. A large panel of mouse anti-human monoclonal antibodies 
(Table I) was produced in our lab and obtained from outside sources. For the new reagents 
(3C10, 1D9, 1E8), a BALB/c mouse (The Trudeau Institute, Saranac Lake, NY) was 
injected intraperitoneally with 108 blood monocytes in saline three times at monthly 
intervals, and four times with 3-5 x 108 monocytes on each of the 4 d before fusion (19). 
For 9.3F10, which recognizes Ia-like or class II major histocompatibility products (see 
Results), exactly the same protocol was used except that dendritic cell-enriched (14) 
preparations were injected into mice. Spleen cells from these mice were fused to P3U 1 
myeloma cells at a ratio of one myeloma cell to five spleen cells as described (20). The 
products of these fusions were seeded at 5 X 104 myeloma cells per 0.32-ram 2 microwell 
(3596; Costar, Cambridge, MA) with 100 /A of hypoxanthine-aminopterine-thymidine 
(HAT) culture medium (Dulbecco's minimal essential medium, supplemented with HAT, 
horse serum, FCS, vitamins, and NCTC 109 medium as described [20]). 
The immunization method of Staehli (19) that we used provided a large number of 
hybrids reactive with human leukocytes, so that a rapid radioimmunoassay was used to 
detect antibodies of interest. A large panel of test cells and cell lines (see above) were 
attached tc Terasaki microassay plates (3034; Falcon Labware, Oxnard, CA) that had 
been exposed to 100 ug/ml poly-L-lysine (70,000 average tool wt; P2636; Sigma Chemical 
Co.) in phosphate-buffered saline (PBS) for 20 min, rinsed in distilled water and dried. 
l Abbreviations used in this paper: FCS, fetal calf serum; HAT, hypoxanthine-aminopterin-thymi- 
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TABLE I 
Monoclonal Mouse Antihuman Leukocyte Antibodies 
Molecular 
Name Ig sub- Source weight of Specificity Reference 
class polypeptide 
T29/33 lgG2b Dr. I. S. Trowbridge, 200,000 All leukocytes (Leu- 21 
Salk Inst., CA kocyte-common 
Ag) 
OKlal IgG2~ Ortho Diagnostic Sys- 34,000, HLA-class II Ag 22 
terns Inc., West- 29,000 
wood, MA 
Ortho Diagnostic Sys- 170,000 
terns Inc. 
OKMI lgGeb Monocytes, natural 3 
killer cells granu- 
locytes, T3' 
Monocytes, granulo- 4 
cytes 
63D3 lgG~ Bethesda Research 200,000 
Laboratories, 
Gaithersburg, MD 
61 D2 IgG2a Bethesda Research 44,000 4 
Laboratories 
Leu 1 IgG2a Becton, Dickinson & 67,000 23 
Co., Oxnard, CA 
3G8 IgG1 Dr. H. B. Fleit, The 66,000, Anti-Fc 3' receptor 16 
Rockefeller Univ. 53,000 on human leuko- 
cytes 
1 B4 IgG2a Dr. S. D. Wright, 182,000, Complement recep- In preparation 
The Rockefeller 123,000, tor (C3bl) on hu- 
Univ. 105,000 man leukocytes 
BA-I IgM Hybritech, Inc., San NA B cells, granulocytes 24 
Diego, CA 
OKT6 lgGi Ortho Diagnostic Sys- 52,000 Thymocytes, Lan- 25 
terns Inc. gerhans' cells 
1 D9 IgGl Authors 55,000 Monocytes This paper 
3C 10 lgG2b Authors 55,000 Monocytes This paper 
1E8 IgG~ Authors ND Monocytes, granulo- This paper 
cytes 
9.3F10 IgG~a Authors 29,000, HLA-class II Ag This paper 
33,000 
HLA-class I Ag 
All T cells 
1-4 x 10 4 cells in 5 -10  #1 of  RPMI 1640 with 0.02% NaNs (azine) were added  to each 
well. The  plate was centr ifuged at 150 g for 5 min at 4°C and quenched in cold RPMI 
1640 with 10% horse serum and azide. After  20 rain, the fluid was aspirated and 10 t~l of  
culture supernatant  was added  for 1 h on ice. The  plates were rinsed by dipping in cold 
PBS with azide, aspirated, and exposed to 10 #1 of  5 # g / m l  125I-F(ab')~ affinity-purified 
rabbit  anti-mouse lgG (specific activity of  6 X l0  s cpm/#g)  in RPMI 1640 with 10% horse 
serum and azide on ice for 30 min. Finally the plates were rinsed, dried, and autoradi-  
ographed for 3 -24  h at - 7 0 ° C  using Kodak XAR5 film (Eastman Kodak Co., Rochester, 
NY) and an intensifying screen (Lightening Plus; Dupont  Co., Wilmington, DE). 
Using this technique, we noted that hybrid wells 3C 10 and 1 D9 reacted with monocytes 
alone; 1E8 with monocytes, granulocytes, and the U937 and HL60 cell lines; and the 
commercially available reagent  OKMI with granulocytes and monocytes. In a similar 
assay, 3C10, 1 D9, and 1 E8 did not  show detectable binding to B cells, T cells, dendrit ic 
cells, and three B cell and two T cell lines, suggesting that the reagents were specific for 
myeloid elements. In contrast,  9.3F10 reacted with monocytes, B cells, dendrit ic cells, 
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HL60, and K562 cell lines, indicating it was an anti-Ia or anti-class II reagent. Many 
additional hybrids were identified with similar reactivity patterns to 3C 10, I D9, 1E8, or 
9.3F10. The latter were cloned in soft agar, and further characterized as described in 
Results. All hybridoma clones produced an Ig-rich ascites in DBA/2 X BALB/c F~ mice. 
Purification and Radiolabeling of Monoclonal Antibodies. Monoclonal antibodies 3C10, 
1Dg, 1E8, and 9.3F10 were purified from ascites using 45% (vol/vol) (NH4)2804 precip- 
itation followed by ion exchange chromatography on diethylaminoethyl cellulose (DE-52; 
Whatman Inc., Clifton, N J). The Ig fraction gave a single band on cellulose acetate 
electrophoresis that co-migrated with the monoclonal band in the unseparated ascites. 
The subclass of  the purified antibody was determined by Ouchterlony analysis using 
subclass-specific antisera prepared in goats (Meloy Laboratories Inc., Springfield, VA) and 
the results are presented in Table I. To  prepare active (see Results) Fab fragments of the 
3C10 antimonocyte and 9.3F10 anti-class II antibodies, Ig at 8 mg/ml  and 5 mg/ml,  
respectively, was digested with 1% (wt/wt) papain (P-4762; Sigma Chemical Co.) in pH 
5.5 0.1 M sodium acetate buffer with 2 mM EDTA and 10 mM 2-mercaptoethanol for 4 
h at 37°C. The reaction was stopped by bringing the solution to 20 mM iodoacetamide. 
The mixtures were dialyzed into 25 mM Tris pH 8.0 and passed over DE-52. Following 
electrophoresis on 11% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) (26) under reducing conditions, the papain digests contained four to five polypep- 
tides, including the candidate Fc, Fd, and light chain portions; the flow-through fractions 
were the presumptive Fab fragments with only two bands (Fig. 1). The intact antibodies 
and digests reacted with subclass-specific antisera, but the flow-through Fab fractions did 
not; all reacted with rabbit anti-mouse IgG (heavy and light chains). 
Antibodies were labeled with Na-~25I (carrier-free; New England Nuclear, Boston, MA) 
using lodo-Gen (Pierce Chemical Co., Rockford, IL) as the oxidizing agent (27) as 
described (2). The iodinated and noniodinated antibodies competed for binding to 
monocytes with equal efficiency (see Results). 
Binding of Monoclonal Antibodies to Cells In Vitro. Indirect immunofluorescence was done 
using a sensitive biotin-avidin system as described (14). Briefly, cells were exposed 
FIGURE 1. Analysis of 3C10 and 9.3F10 Ig and Fab fragments. One-dimensional 11% SDS- 
PAGE was run under reducing conditions and stained with Coomassie brilliant blue. 3C10 is 
antimonocyte and 9.3F10 is an anti-HLA class II. For each antibody, samples were analyzed 
from the purified Ig fraction (ascites passed over diethylaminoethylcellulose), the papain (Pap) 
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successively to: (a) mouse anti-human monocional antibody, (b) biotinylated horse anti- 
mouse Ig (Vector Laboratories Inc., Burlingame, CA), and (c) fluorescein-avidin (Vector 
Laboratories Inc.). Biotinylated horse anti-human Ig (Vector Laboratories Inc.) was used 
at 20 #g/ml to stain B cells. 
Quantitative binding studies with monoclonal antibodies were performed at 4°C with 
cells attached to 16-mm poly-L-iysine-coated macrowells (3524; Costar) as described above 
for the screening radioimmunoassay, except that the volume of the well was always 
maintained at 0.25 ml; 1-4 × 105 cells were used per well; and the bound radioactivity 
was determined by wiping the cells with cotton swabs and counting these in a Packard 
gamma counter (Packard Instrument Co., Downers Grove, IL). Additional details are 
provided in the legends to Tables IV-V. 
Quantitative binding studies were used to monitor the effect of protease treatment on 
monocyte-specific and class II antigens. Treatment with proteases was done in suspension 
at 5 × 106 cells/mi in PBS with 1 mg/mi  of either TPCK-trypsin (T8642), chymotrypsin 
(C4129; Sigma Chemical Co.), or pronase (53702; Calbiocbem-Behring Corp., La Jolla, 
CA) for 15 min at,37°C; or by 0.1 IU/ml  neuraminidase (vibrio cholerae; 480717; 
Calbiochem-Behring Corp.) for 45 min at 37°C. Viability was >90% by trypan blue 
exclusion after each treatment. Cells were then centrifuged onto poly-L-iysine-coated 16- 
mm wells at 4 × 105 cells per well, and the amount of antigen was quantified as above. 
Ident~cation of the Polypeptide Carrying the 3C10/1D9 Monocyte Antigen. The "western 
blot" procedure was modified slightly from those described by Towbin et al. (28) and 
× 10 adherent cells were soluhilized in lysis buffer, i.e., Johnson et al. (29). In brief, 5 6 
PBS with 0.5% NP40 detergent, 0.2 trypsin inhibitory units trasylol (aprotinin; A-6012) 
and 2 mM phenylmethylsulfonylfluoride (P-7626; Sigma Chemical Co.). The lysate was 
cleared by centrifugation at 600 g for 10 min, and then 20,000 g for 20 min. The iysate 
was mixed 1:1 with sample buffer (4% SDS, 24% sucrose, 0.05% bromphenol blue, 100 
mM Na2CO3, pH 8.5), boiled for 2 min, and electrophoresed 10 cm on a 1-mm, 4-11% 
gradient SDS-PAGE. The proteins were transferred from the gel lane onto nitrocellulose 
(BA85; Schleicher & Schuell, Inc., Keene, NH) by electrophoresis. The nitrocellulose 
filter was incubated for 16 h with PBS-Tween (10% horse serum, 0.1% gelatin, 0.1% 
NaNa, 0.05% Tween 20 in PBS), which served as both wash and carrier buffer for all 
incubations. The filter was exposed at 4°C for 20 h to either directly 125I-labeled 
monoclonal antibody or unlabeled monoclonal antibody (sandwich assay), washed four 
times over 45 rain at room temperature and, for the sandwich assay, exposed to 125I- 
F(ab')2 rabbit anti-mouse Ig at 4°C for 20 h. The blot was then washed extensively and 
autoradiographed for 16-48 h as above. 
The immunoprecipitation procedure was carried out on overnight-cultured, adherent 
mononuclear cells that were surface labeled with '25I and iactoperoxidase/glucose oxidase 
(30). The cells were solubilized and cleared by centrifugation as described above. Then 
SDS was added to a final concentration of 0.2%, and the lysate was preabsorbed for 1 h 
at 4°C with 100 /agm crude mouse immunoglobulin (45% (NH4)~SO4 precipitate of 
nonimmune mouse serum) coupled to Sepharose 4B (Pharmacia Fine Chemicals, Piscata- 
way, NJ), per 106 cell equivalents. The supernatant representing 106 cell equivalents was 
then absorbed with 100 #gm of antibody coupled to Sepharose 4B for 1 h at 4°C. The 
beads were washed three times in lysis buffer with 2% FCS and two times in lysis buffer 
alone. The antigen was released by boiling with sample buffer and 50 mM dithiothreitol 
and electrophoresed for 20 cm. The gel was dried and autoradiographed for 7 d. 
Complement-mediated Cytotoxicity. Killing with antibody and rabbit complement was 
accomplished by exposing cells (1.7-2.5 x 106 cells/ml) to antibody (3C10 antimonocyte 
at I0 #g/ml; 9.3F10 anti-Ia at 3/zg/ml; Leu-1 anti-T cell at 3 gg/ml; BA-1 anti-B cell at 
3 #g/mi) and rabbit serum (selected for low background cytotoxicity and stored at - 7 0  °C 
after lyophilization; 1:9 final dilution) for 1 h at 37°C. All reagents were diluted in 0.3% 
bovine serum albumin, 25 mM Hepes, RPMI 1640 pH 7.4, and deoxyribonuclease 
(DNAase I; Sigma Chemical Co.) was present at 10 t~g/ml. The percentage killed was 
determined by the reduction of viable cells (trypan blue exclusion test) as compared with 
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complement alone, active complement alone, and heated complement plus antibody. The 
standard error of the averaged controls was <10%. The percentage of monocytes was 
monitored by staining cytocentrifuge preparations with a-naphthyibutyrate for nonspecific 
esterase according to the method of Li et al. (31). Cells with diffuse red cytoplasmic 
staining were scored as monocytes. Staining for myeloperoxidase, with diaminobenzidine 
tetrahydrochioride and hydrogen peroxide (32), was also used to count monocytes with 
similar results. However the percentage of monocytes that were peroxidase positive 
diminished to ~ 50% after overnight culture. 
Dendritic Cell Purification with Cytotoxic Cell-specific Antibodies. To enrich for dendritic 
cells using cell-specific antibodies, we began by treating 0.5-5 × 108 blood mononuclear 
cells with 3C 10 antimonocyte antibody and complement, or complement alone as outlined 
above. The cells were washed and adhered in 100-mm plastic culture dishes for 1 h at 
37°C in 5% FCS medium. The nonadherent cells were removed with five rinses and the 
adherent monolayers were cultured for 18 h. Most of the adherent cells had released 
from the plastic, and these were retreated with 3C10 as well as BA-1 and Leu-1 (anti-B 
and -T cell, respectively) antibodies and complement, or just complement for the control 
cells. Almost all of  the viable cells (~80%) were retrieved by flotation in columns of dense 
bovine plasma albumin (P = 1.082) as described (14). This fraction was highly enriched 
for dendritic cells (see Results). An alternative approach to eliminate monocytes was to 
treat mononuclear cells with 3C10 antibody and complement after, rather than before, 
adherence to plastic. The former requires less complement, but the latter approach was 
used in this paper to establish that normal numbers of dendritic cells adhere to plastic 
after elimination of most monocytes. 
Staining Tissue Sections with Monoclonal Antibodies. Skin biopsies were obtained by Dr. 
W. R. Levis (The Rockefeller University) from patients with leprosy, but normal skin 
samples were also stained. Spleen and lymph node were provided by the Tumor Procure- 
ment Center of Memorial Sloan-Kettering Cancer Center, New York. The tissues, which 
did not contain tumor cells, were frozen in liquid nitrogen, embedded in OCT embedding 
medium (Lab-Tek Div., Miles Laboratories Inc., Naperviile, IL), sectioned at 6-8 #m 
with a cryostat, and stored at -20°C. The sections were fixed before staining for 30 s 
with ice-cold acetone. Immunoperoxidase staining was done as previously described for 
immunofluorescence of tissue sections (33), except that after treatment of tissue sections 
with monoclonal antibody and biotinylated horse-anti-mouse IgG, the sections were 
treated with 20 #g/ml avidin-horseradish peroxidase (Vector Laboratories Inc.), and 
developed with 0.4 mg/ml 3,3' diaminobenzidine tetrahydrochloride (Polysciences Inc., 
Warrington, PA) in 0.05 M Tris buffer, pH 7.6, with 0.01% HeO2 for 10 min at room 
temperature. Sections were stained for 3 min with Gill's hemotoxylin (formulation 1; 
Fisher Scientific Co., Fairlawn, N J). 
Resu l t s  
T h e  purpose  o f  this study was to develop monoclonai  antibodies that reacted 
only with mononuc lea r  phagocytes in blood and in tissues, and not  with dendrit ic 
cells. T h e  monocionais  could then be used to help purify dendrit ic cells f rom 
blood and to show that macrophages  and dendri t ic  cells occupy distinct anatomic 
compar tments  in spleen, lymph node,  and skin. 
Cell Specificity of 3ClO, ID9, and 9.3F10 Monoclonal Antibodies. Initial screening 
with a microradioimmunoassay (see Materials and Methods) indicated that 3C 10 
and 1 D9 reacted with monocytes,  whereas 9.3F10 reacted with many cell types 
and lines known to express class II H L A  products.  After  cloning, we evaluated 
cul ture  supernatants,  purif ied Ig, and Fab fragments,  for  reactivity with a large 
panel of  cell types using immunof luorescence  and a sensitive biotin-avidin tech- 
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panel of  other cell types (Table II). A small percentage of cells were stained in 
the B cell- and dendritic cell-enriched populations, but this percentage corre- 
sponded to the number of contaminating monocytes estimated by cytologic 
criteria or by nonspecific esterase staining. 9.3F10 stained most monocytes, B 
cells, and dendritic cells, but not T cells, platelets, and granulocytes (Table II). 
9.3F 10 stained similarly to OKIa (22), further suggesting that it recognized class 
II HLA antigens. The Fab fragments of 3C 10 and 9.3F 10 stained a similar panel 
of cell types to the corresponding intact Ig (not shown). Leu-1 and anti-Ig reacted 
with most cells in the T and B cell-enriched populations, respectively, but not 
with monocytes, dendritic cells, and other cell types (Table II). 
By indirect immunofluorescence, the 3C 10 antigen was stable in culture. Thus 
3C10 was expressed on 95% of monocytes that had been cultured for 45 d in 
teflon beakers to retard adherence (Table II). Glass-adherent monocytes were 
3C10 + for 21 d, but at 28 d about 25% became 3C10-. The latter frequently 
were multinucleated giant cells. Alveolar macrophages, obtained by bronchial 
lavage, were all stained with 3C10 and 3C10 Fab fragment, but not with the T 
lymphocyte specific marker, Leu-1 (Table II). 
In the presence of rabbit complement, 3C10 killed >95% of purified mono- 
cytes but did not kill populations enriched in other cell types (not shown). 9.3F 10 
killed 30-70% of monocytes, as well as most B cells and dendritic cells. 3C10 
efficiently and selectively depleted monocytes from heterogeneous mixtures of 
unfractionated mononuclear cells or plastic-adherent cells (Table III). Total cell 
killing precisely paralleled the loss of cells that stained diffusely for nonspecific 
esterase, an independent monocyte marker (Table III). >95% of the esterase- 
TABLE II 
Reactivity of Monoclonal Antibodies with Different Cell Types 
Cells 
Percentage of cells positive after staining with: 
Anti-Hu- Anti-HLA Percent 
3C10 9.3F10 OKIa Leu-1 man Ig class I monocytes 
PBMC* 1 30 28 26 60 7 100 31 
PBMC 2 25 23 24 53 14 100 25 
Monocytes 95 78 78 1 2 100 96 
Granulocytes <1 <1 <1 ND <1 100 <1 
Dendritic cells 10 100 100 6 44 100 10 
T Cells (E,+) 1 5 5 95 2 100 1' 
T lymphoblasts 1 7 7 85 1 100 1 
Non-T (E,-)  4 37 33 8 24 100 4* 
B cells 2 84 81 19 78 100 2 
B lymphoblasts 1 84 82 21 68 100 1 
Erythrocytes 0 0 0 0 0 ND 0 
Platelets 0 0 0 0 0 100 0 
45-d cultured monocytes 100 100 ND 0 ND ND 100 
Alveolar macrophages 98 99 ND 0 ND ND 98 
Enriched populations of various cell types were prepared as described in Materials and Methods. 
The dendritic cell-enriched fraction was 29% dendritic cells, 55% lymphocytes, and 10% monocytes 
by morphology. The percent monocytes was generally determined by morphology, i.e., circumfer- 
ential spreading, ruffles, large-phase dense lysosomal granules. ND, not done. 
" Peripheral blood mononuclear cells. 
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TABLE III  
Summary of Cytotoxicity Experiments with Antimonocyte and Anti-Ia Antibodies and Rabbit 
Complement 
Untreated Antibody- and comple- 
cells ment-treated cells 
Population Antibody n 
Percent ester- Percent Percent es- 
ase ÷ killed terase ÷ 
Peripheral blood 3C10 11 31 + 8 27 + 9 2 ± 1 
mononuclear cells 9.3F10 4 31 + 9 20 ± 7 14 ± 13 
Adherent mononuclear 3C10 5 54 + 9 52 _ 6 2 - 2 
cells 9.3F10 I 54 65 35 
Unfractionated mononuclear cells or plastic-adherent cells (released after overnight culture) were 
treated with antimonocyte (3C10) or anti-la (9.3F10) antibodies and rabbit complement. We then 
counted the percent (mean + standard error) of cells that were stained diffusely for nonspecific 
esterase in aliquots of untreated and antibody plus complement-treated cells. The percent killed was 
determined by trypan blue staining. 
TABLE IV 
Number of 3ClO, 1D9 (Antimonocyte), and 9.3F10 (Anti-la) Binding Sites per Monocyte 
~2sI-labeled antibody 
ng of antibody bound per 4 X 105 monocytes 
(molecules of antibody bound per monocyte) 
Experiment A Experiment B Experiment C 
3C10 (intact lg) 3.6 (38,000) 4.9 (47,000) - 
3C10 (Fab fragment) 1.3 (38,000) 1.5 (46,000) 1.0 (37,000) 
1 D9 (intact Ig) 3.4 (34,000) - - 
9.3F10 (intact Ig) 23 (230,000) - - 
- 7.5 (225,000) 9.3F 10 (Fab fragment) 
In experiment A, saturating doses of ~2~I-antibody (3-12 t~g/ml) were added, while in experiment B, 
a constant dose of ~5I-antibody (0.2 •g/ml for intact and 1.0 ~g/ml for Fab) was mixed with varying 
doses of unlabeled antibody (0-12 t~g/ml for intact, 0-32 tag/ml for Fab). The values given are 
means of at least three saturating doses, the standard deviation being <10%. Nanograms of antibody 
bound was determined by: [(cpm bound - no-cell control)/specific activity of the antibody]. The no- 
cell control was <2% of the total bound. 1 ng of intact Ig (~  150 kD) was assumed to be 4.0 × 109 
molecules and 1 ng Fab (~50 kD) 1.2 × 10 t° molecules. The monocytes were studied after 1 d of 
culture. 
pos i t ive  cells we re  k i l l ed  a n d  the  p r e p a r a t i o n s  r e m a i n e d  m o n o c y t e  d e p l e t e d  fo r  
>1  wk in c u l t u r e .  In  c o n t r a s t ,  t he  cy to ly t ic  ant i -c lass  I I  r e a g e n t  9 . 3 F 1 0  d i d  n o t  
kill  all t he  m o n o c y t e s  j u d g e d  to be  9 . 3 F 1 0  r eac t i ve  by  i m m u n o f l u o r e s c e n c e  
( T a b l e  I I I ) .  W e  c o n c l u d e  t ha t  3 C 1 0  a n d  1D9 r e c o g n i z e  an  a n t i g e n  t ha t  is 
m o n o n u c l e a r  p h a g o c y t e  specif ic  a n d  is p r e s e n t  o n  mos t  i f  n o t  all  f r e sh  a n d  
c u l t u r e d  m o n o c y t e s  a n d  a l v e o l a r  m a c r o p h a g e s .  
Quantitative Binding Studies. S a t u r a b l e  b i n d i n g  o f  t he  a n t i m o n o c y t e  a n d  an t i -  
class I I  m o n o c l o n a l  a n t i b o d i e s  o c c u r r e d  a t  0 . 3 - 1 . 0  # g / m l  fo r  1 - 4  x 105 cells. 
M o n o c y t e s  e x p r e s s e d  3 . 7 - 4 . 7  x 104 b i n d i n g  sites fo r  3C 10, 3C 10 Fab ,  a n d  1 D9, 
a n d  1 . 3 - 2 . 3  x 105 b i n d i n g  sites fo r  t h e  ant i -c lass  I I  r e a g e n t ,  9 . 3 F 1 0 ,  a n d  its F a b  
f r a g m e n t  (see T a b l e  IV).  W h e n  m o n o c y t e s  w e r e  c u l t u r e d  fo r  6 d,  t he  n u m b e r  
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Quantitative binding studies (not shown) established that the molecule carrying 
the 3C10 antigen was sensitive to trypsin, pronase, and chymotrypsin but not to 
neuraminidase. The  9.3F10 Ia-like determinant  was not protease sensitive. 
Binding of  125I-3C10 was blocked by cold 1D9 or cold 3C10 Fab (Table V). 
However, all the other  antibodies in our  panel (Table 1), which included several 
antibodies to HLA-class I and II antigens did not  inhibit 3C 10 binding (see Table 
V). We conclude that 3C10 and 1D9 bind to a similar, non-HLA determinant ,  
and that binding is not Fc mediated. 
Identification of Polypeptides Bearing the 3C10, ID9, and 9.3FI0 Antigens. 3C10 
precipitated a major 55 kD polypeptide from monocytes that had been surface 
radiolabeled with Na-12~I and lactoperoxidase-glucose oxidase (Fig. 2, left). The  
same polypeptide was identified with 3C 10 Fab. As anticipated, 9.3F 10 reacted 
with a 33-29 kD doublet  typical of  the alpha and beta chains of  HLA-class II 
products (Fig. 2). 
By Western blotting, 3C10 (Fig. 2, right) and 1D9 (not shown) again reacted 
with a 55 kD polypeptide. In some blots, a minor 53 kD band reacted with 3C10. 
This might have represented an intracellular precursor for the 55 kD 3C10 
surface polypeptide (Fig. 2, right). 
Use of Antimonocyte Antibodies in the Purification of Dendritic Cells. Although 
blood dendritic cells adhere  to plastic, they are far ou tnumbered  by monocytes 
(~20-fold)  and lymphocytes. We first noted that 3C10 (antimonocyte), BA-1 
(anti-B cell), and Leu-1 (anti-T cell) efficiently killed populations enriched in 
monocytes, B cells, and T cells, respectively, but not dendritic cells (not shown). 
We therefore devised a procedure (see Materials and Methods) in which mono- 
cyte-depleted adherent  cells were prepared, cultured overnight,  and reexposed 
to complement and a battery of  monoclonals: 3CI0,  BA-1, and Leu-1. 80% of 
the cells that survived cytolysis could be floated free from the dead cells on dense 
albumin columns. The  recovery was 0.1-0.2% of  the total starting mononuclear  
cells. By cytology (Fig. 3, a-c), ~ 7 0 %  of the final low density population were 
TABLE V 
Competition for Ie~I-3C10 Binding by Unlabeled Antibodies 
Unlabeled antibody 
Percent binding 
Mean cpm compared to no 
minus back- unlabeled anti- 
ground body 
No unlabeled antibody 11,258 - 
9.3F 10 (anti-la) 10.715 95 
1 E8 (antigranulocyte monocyte) 10,737 95 
T29/33 (antileukocyte) 11,312 100 
1 B4 (anti-Csb~ receptor) 15,510 138 
1 D9 (antimonocyte) 956 8 
3C 10 (antimonocyte) 135 1 
3G8 Fab (anti-Fc 3" receptor) 10,751 95 
3C 10 Fab (antimonocyte) 1,085 10 
L~Sl-3C10 (1 #g/ml) was added to 4 x 105 monocytes that previously had 
been exposed for 60 rain to either no other antibody, or to saturating 
levels (50 vg/ml for all except T29/33, which was 1:100 dilution of 
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FIGURE 2. Immunoprecipitation (left) and immunoblotting (right) analysis of the polypeptides 
carrying the 3C 10 and 9.3F 10 antigens. In the immunoprecipitation experiment, a radioiodi- 
nated monocyte lysate was precleared on Sepharose coupled to mouse Ig and then divided 
into aliquots for precipitation with Sepharose coupled to 3C 10 (antimonocyte), I E8 (antimon- 
ocyte, granulocyte), 9.3F10 (anti-class II), or mouse lg. The blotting experiment used directly 
labeled 1~5I-3C10 Ig at 0.08 ttg/ml, 7 × 108 cpm/~g; or an indirect approach (3C10 at 1 #g/ 
ml followed by J25I-F(ab )~ rabbit anti-mouse Ig at 0.05 ttg/ml, 6 x 10° cpm/#g). 
dendritic cells, and total yield was comparable to controls that had been exposed 
to complement only (Table VI). The  dendritic cell fraction contained <1-4% 
monocytes, identified by cytology or nonspecific esterase staining. Likewise B 
and T cells were depleted to <2%, as monitored by immunofluorescence with 
anti-Ig and Leu-2a and -3a antibodies. Controls exposed to complement in the 
absence of  antibodies were ,-,70% monocytes (Table VI, Fig. 3d). Therefore, 
dendritic cells in blood (---,0.5% of total mononuclear cells) can be purified by a 
technique that uses their adherence property and the fact that they lack the 
differentiation markers of  other cell types. 
Distribution of Macrophages in Tissue Sections. Since 3C10 reacted with all 
monocytes and alveolar macrophages, but not with dendritic cells, this antibody 
was used to outline the distribution of  macrophages in frozen sections of  spleen, 
lymph node, and skin. In spleen, both 3C 10 and 3C 10 Fab stained large numbers 
of macrophages in the red pulp (Fig. 4). Lymphocytes in white pulp, fibroblasts 
in connective tissue trabeculae, and endothelial and smooth muscle cells of  blood 
vessel walls were not stained. White pulp nodules, which probably contained 
most of  the dendritic cells (34, 35), had few 3C10 + cells in either T (Figs. 4, 5) 
or B (not shown) regions. Some 3C 10 ÷ cells, presumably macrophages, abutted 
the central white pulp arteries (Fig. 5). Leu- 1 stained collections o f t  lymphocytes 
close to the central arteries (Figs. 4, 5) as well as scattered cells in both red pulp 
(Fig. 4) and B cell follicles (not shown). The anti-Ia antibody, 9.3F10, stained 
both red and white pulp intensely. Ia ÷ cells in T-dependent areas probably 
corresponded to dendritic or interdigitating cells (see Discussion) and far out- 
numbered 3C 10 + macrophages (Fig. 5). 
In node (Fig. 6), 3C 10 ÷ cells were abundant along all of the lymphatic channels. 
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FIGURE 3. Phase-contrast microscopy of low density adherent cells from blood. (a-c) Purified 
dendritic cell fraction, prepared by cytolytic elimination of monocytes and lymphocytes as 
described in Materials and Methods. Most of the cells exhibit the typical dendritic appearance 
described previously (14). (d) Control low density population exposed to complement only; 
most of the ceils have the characteristic features of monocytes, while ~ 10% are dendritic ceils 
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TABLE VI  
Preparation of Human Dendritic Cells by Eliminating Other Cell Types with Monoclonal 
Antibodies and Complement 
Treatment  
Starting num- Number oflow- 
ber of mono- density adher- 
nuclear cells ent cells 
Differential count of low-density 
fractions 
DC Monocytes Lymphs 
Experiment 1 
Complement only 5 × 107 
Complement + 3C10 2 x 108 
Experiment 2 
Complement only 
Complement + antibodies 
(3C10 + BA-I + Leu-1) 
Experiment 3 
Complement only 1 × 10 a 
Complement + antibodies 5 × 10 s 
(3C10 + BA-1 + Leu-1) 
% 
1.4 X 106 8 80 12 
5 X 105 43 I 57 
1.5 X 10 a 7 X 106 7 62 31 
3.5 X 108 6 X 105 76 1 23 
4.6 x 106 12 71 17 
5 x 105 80 1 20 
Mononuclear cells were obtained from FicolI-Hypaque columns and processed, as described in 
Materials and Methods, to deplete the adherent  fraction of monocytes. Then  the adherent  cells that 
came off the plastic surface after overnight culture were treated again with complement with or 
without monoclonal antibodies as indicated. The  cells resistant to cytolysis were recovered on albumin 
columns (low-density adherent  cells) and analyzed by phase-contrast microscopy. Round cells were 
classified as ~lymphocytes" since they did not look like dendritic cells (DC) or monocytes; however 
the BA-1- and Leu-l-treated populations lacked typical B and T cells by surface markers (see Results). 
intermediate sinuses that penetrate the cortex along connective tissue trabeculae; 
and the medullary cords that contain the efferent lymphatics. BC10 reactivity 
was also noted in the center of  secondary follicles (germinal centers; not shown). 
However, 3C10 + cells were scarce in thymus-dependent regions (identified by 
abundant Leu-l-positive T cells, and the presence of postcapillary venules) and 
in follicular collections of small B cells (Fig. 6). 
In normal skin (not shown), a few 3C10 + cells were scattered in the dermis. In 
epidermis, Langerhans' cells were stained with OKT 6 (25), T29 /33  (antileu- 
kocyte) (21), and 9.3F10 (anti-Ia) reagents, but not with 3C10. Skin biopsies 
were also studied from patients with lepromatous leprosy (Fig. 7), since these 
contain macrophage-rich dermal infiltrates and in many cases, abundant epider- 
mal Langerhans' cells (33). The infiltrates contained many 3C 10 ÷ cells, but again 
epidermal Langerbans' cells failed to stain with 3C 10 (Fig. 7). 
We conclude that 3C10 identifies mononuclear phagocytes that are resident 
in dermis, lymph node, and spleen, and that migrate into inflammatory foci. Few 
macrophages are noted in those regions considered to be rich in dendritic cells; 
that is, the two cell types are segregated anatomically. 
Discussion 
We have described an antigen that is widely distributed on human mononuclear 
phagocytes. The antigen is detected by the monoclonal antibodies, 3C10 and 
1D9, and is present on most if not all blood monocytes, alveolar macrophages, 
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FIGURE 4. Immunocytochemistry of the junction (dotted line) of red and white pulp in 
spleen. Adjacent sections were stained with no primary antibody (a); 3C10 antimacrophage 
(b); and Leu-1 anti-T cell (c). The red pulp contains some opaque profiles (a) which represent 
background staining occurring in the absence of primary antibody. The red pulp has many 
3C10 ÷ macrophages (b, arrows) and scattered T cells (c). The white pulp nodule, with central 
arteries (arrowheads), contains an area rich in Leu-I ÷ cells (T area) that lacks 3C10 ÷ cells. 
x 200. 
probably recognize a related if not  identical antigen. Specifically, the reagents 
compete  for  binding to monocytes  and immunoprecipi ta te  a similar 55 kD surface 
molecule. In both binding and immunoprecipi ta t ion assays, 3C10 Fab behaves 
identically to intact Ig (Tables IV, V, Fig. 2). This is impor tant  since monocytes  
exhibit  Fc receptors,  which have a molecular  weight o f  "~55,000 (16, 20). T h e  
3C10-1D9 antigen is clearly distinct f rom HLA-class II or  Ia-like determinants  
which in this paper  were identified primarily with a new monoclonal,  9.3F10 
(Tables I I - IV ,  Fig. 2). O f  the many ant imonocyte  antibodies that have been 
produced,  3C 10 and 1 D9 most closely resemble the anti-Mo2 reagents described 
by T o d d  et al. (7, 10). 
Use of Antimonocyte Antibodies in the Purification of Dendritic Cells. T h e  3C10 
and ID9 antibodies do not  stain (Table  II) or kill dendri t ic  cells enr iched as 
described previously (14). In fact elimination o f  monocytes  with 3C 10 ant ibody 
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FIGURE 5. Immunocytochemistry of  the periarterial region of splenic white pulp. Adjacent 
sections were stained with 9.3F 10 anti-Ia (left), 3C I 0 antimacrophage (middle), and Leu-1 anti- 
T cell (right). The sections illustrate that the T area has few macrophages but many la ÷ cells. 
The latter probably include interdigitating or dendritic cells (see Discussion). x 200. 
purity and yield (Table VI, Fig. 3). The enriched fractions that can be depleted 
of B and T cells, with BA-1 and Leu-1 antibodies, contain 65-80% dendritic 
cells. The identity of the remaining 20-35% is unclear but could include dendritic 
cells that do not spread well at the time of assay. In the accompanying paper 
(36), we also show that heterogeneous cell mixtures can be separated into 1D9 ÷ 
and 1 D9- fractions; the former are highly enriched in monocytes and the latter 
contain the dendritic cells. 
The availability of the 3C10-1D9 antibodies is particularly timely, since the 
separation of dendritic cells from mononuclear phagocytes in man (14) is more 
demanding than in mouse (12). In both species, dendritic cells adhere to plastic 
and account for <1% of total nucleated cells. However, human blood contains 
large numbers of adherent monocytes (55-30%); mouse lymphoid tissues release 
<5-2% adherent macrophages. Both monocytes and dendritic cells in man have 
a low buoyant density; in mouse, most (,--2/3) dendritic cells float on dense 
albumin columns, whereas most macrophages typically pellet. These experimen- 
tal difficulties can be overcome by using 3C10 and 1 D9 to identify and separate 
the two cell types (Tables II, VI, Fig. 3). The experiments described here 
represent the first time that antimacrophage antibodies have been used in the 
purification of dendritic cells. 
Distribution of Macrophages and Dendritic Celts in Tissues. Both 3C10 and its 
Fab fragment are effective for immunocytochemical staining of tissue sections. 
Endothelial cells, fibroblasts, lymphocytes, and dendritic cells do not stain with 
3C10, but many 3C10 ÷ cells are found in regions that are known to be rich in 
macrophages: the red pulp of spleen; the areas surrounding lymphatic vessels in 
lymph node capsule, cortex, and medulla; and the dermal inflammatory infiltrates 
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FIGURE 6. lmmunocytochemistry of  lymph node cortex. Adjacent sections were stained with 
Leu-1, anti-Z cell (left) and 3C10, antimacrophage (right). Lymph node cortex contains two 
kinds of  lymphatic tissue: one is rich in Leu-1 ÷ T cells (T) and contains many postcapillary 
venules (I0; the other contains follicles of  Leu-1- B cells (F). Penetrating the cortex are 
connective tissue trabeculae (X) that course from subcapsular cortex to the hilum. The  
trabeculae are lined with lymphatic channels (not evident in frozen sections) and sheets of 
3C10 + macrophages (region with dotted line), x 160. 
neously, we cannot be certain that all tissue macrophages stain with 3C10. 
However, the staining is prominent, and the number of  reactive cells is abundant. 
It seems likely that 3C10 acts as a panmacrophage reagent in the tissues we have 
studied. 
Strikingly, 3C 10 + cells are not found in several compartments that are thought 
to be rich in dendritic cells: white pulp of  spleen, cortical lymphatic tissue of 
node, and epidermis (Figs. 4-7). Staining with 3C 10 therefore reveals that most 
macrophages and dendritic cells are segregated from one another, a distinction 
that has never been so dramatically evident. In mouse spleen, dendritic cells can 
be isolated from white but not red pulp (34), and can be visualized by electron 
microscopy in white pulp (35). The white pulp dendritic cells resemble the 
"interdigitating cells" (37, 38) first described by Veldman. Interdigitating cells 
are concentrated in thymus-dependent regions of lymphoid organs in all mam- 
mals. Several studies have likened interdigitating cells in tissue sections to 
dendritic cells isolated in vitro (39, reviewed in 40). In epidermis, Langerhans' 
cells are stellate, bone marrow-derived, and Ia + (reviewed in 41). Human Lan- 
gerhans' cells, identified in this study by their reactivity with anti-Ia, anti- 
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FIGURE 7. lmmunocytochemistry of a skin biopsy from a patient with lepromatous leprosy. 
Adjacent sections were stained with OKT6, anti-Langerhans' cell (left) and 3C10, antimacro- 
phage (right). A network of  Langerhans' cell processes is evident in the epidermis, but this 
network lacks the 3C 10 determinant. In contrast, the dermal infiltrates of leprosy represent a 
dense network of 3C 10 + O KT6- macrophages, and (not shown) OKT 8*4- lymphocytes (33). 
Although Langerhans' cells can increase in number in leprosy epidermis (33), their surface 
markers (OKT6 +, 3C10-, Ia ÷) are comparable to normal skin. x 160. 
hans' ceils do not react with the F4/80, mac-l, and 2.4G2 monoclonals (Witmer 
and Steinman, unpublished results), each of which binds to macrophages but not 
to dendritic cells (2). Therefore Langerhans' cells, which frequently are likened 
to macrophages, may be part of the dendritic cell system. 
The segregation of macrophages and dendritic cells in spleen and lymph node 
seems appropriate for the two main functions performed by lymphoid organs--  
clearance of antigen, and development of immune responses. The macrophage 
is the "versatile element of inflammation" (42). It is endowed with endocytic and 
microbicidal capacities, and these functions are enhanced by the Ig and lympho- 
kine products of stimulated iymphocytes. Macrophages are concentrated in those 
regions where antigen first leaves vascular and lymphatic channels, namely the 
red pulp of spleen and the lymphatic sinuses of node. Therefore, macrophages 
are positioned to scavenge and clear antigen, and likely constitute a major first 
line of host defense. In contrast, dendritic cells are "nature's adjuvant," the 
principal accessory cell required for the stimulation of many lymphocyte re- 
sponses (13). Dendritic cells likely are poised near recirculating lymphocytes, and 
are accessible to antigen that escapes macrophage clearance. Although additional 
immunocytochemical studies of antigen-stimulated tissues are needed, during 
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poor and dendritic cell rich (see 43-46). These anatomical findings are an 
important adjunct to in vitro studies that compare the accessory function of 
human macrophages and dendritic cells. The latter are the subject of the 
accompanying paper (36). 
Summary  
3C 10 and 1 D9 are two related monoclonal antibodies that specifically identify 
human mononuclear phagocytes in a large number of sites, including blood 
monocytes, alveolar macrophages, and macrophages in tissue sections of spleen, 
lymph node, and skin. The antigen persists on monocytes cultured for >4 wk, 
but it is not found on giant cells. The 3C10-1D9 determinant is carried by a 55 
kD polypeptide, is expressed at ~40,000 copies per monocyte, and is protease 
sensitive. The antigen is clearly different from HLA-class II or Ia-like antigens 
that have been studied with a new monoclonal 9.3F10. The 9.3F10 antigen is 
found on B cells, dendritic cells and monocytes; is protease resistant, and occurs 
on a 33-29 kD doublet typical of class II products. 
The 3C10 monoclonal provides a clear distinction between human mononu- 
clear phagocytes and dendritic cells. First, monocytes and lymphocytes can be 
eliminated from plastic-adherent mononuclear cells using 3C10, complement, 
and two previously described cytotoxic antibodies, BA-1 (anti-B cell) and Leu-1 
(anti-T cell). As a result, the trace dendritic cell component of blood can be 
enriched to considerable purity (65-75%) and yield. Second, immunocytochem- 
ical staining of tissue sections reveals that 3C 10 + macrophages are anatomically 
segregated from dendritic cells. Large numbers of 3C10 + cells are found in red 
pulp of spleen and in regions surrounding lymphatic channels of lymph node. 
However, 3CI0 + macrophages are scarce in white pulp of spleen and the 
lymphocyte-rich cortex of node that are the sites where dendritic cells are 
localized. 3C10 + cells in skin are found in the dermis, particularly in leprosy 
infiltrates, but the Langerhans' cells of epidermis are 3C10-. The distinctive 
localization of macrophages and dendritic cells is consistent with their respective 
functions as effector and accessory cells in the immune response. 
Received for publication 16 March 1983. 
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